Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...

Evercore ISI analyst Amit Daryanani maintained a Buy rating on Dell Technologies (DELL – Research Report) yesterday and set a price target of ...

In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Hartford Financial (HIG – Research Report), with ...

Genstar Capital, a leading private equity firm focused on investments in targeted segments of the financial services, ...

Trump directed a US agency to limit Chinese spending on technology and other strategic US sectors. Read more at ...

Venturi Wealth Management LLC increased its holdings in T. Rowe Price Group, Inc. (NASDAQ:TROW – Free Report) by 125.4% ...

Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss the markets, Meta's historic winning ...

Rich Ross, head of technical analysis at Evercore ISI, said that a breakout to an all-time high in the S&P 500 ( SP500 ), ( ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6, citing discounted valuation, a potential industry turnaround ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

QuantumScape (NYSE:QS – Get Free Report) had its price target lowered by analysts at Evercore ISI from $10.00 to $8.00 in a ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.